Edition:
United Kingdom

Natco Pharma Ltd (NATP.NS)

NATP.NS on National Stock Exchange of India

1,010.25INR
10:29am GMT
Change (% chg)

Rs-12.80 (-1.25%)
Prev Close
Rs1,023.05
Open
Rs1,016.05
Day's High
Rs1,029.00
Day's Low
Rs1,000.00
Volume
174,920
Avg. Vol
314,961
52-wk High
Rs1,090.00
52-wk Low
Rs605.80

Select another date:

Mon, Dec 18 2017

BRIEF-Natco Pharma Launches Tafnat, Tenofovir Alafenamide Tablets In India

* SAYS NATCO LAUNCHES TAFNAT, TENOFOVIR ALAFENAMIDE TABLETS, FOR TREATMENT OF CHRONIC HEPATITIS B, IN INDIA Source text for Eikon: Further company coverage:

BRIEF-Natco Pharma Approved Allocation Of 10 Mln Shares At 915 Rupees/Share Upon Closure Of QIP

* NATCO PHARMA - APPROVED ALLOCATION OF 10 MILLION SHARES AT ISSUE PRICE OF 915 RUPEES PER SHARE UPON CLOSURE OF QIP Source text: http://bit.ly/2zbT0ZA Further company coverage:

BRIEF-Natco Pharma Approves QIP Floor Price Of 937.63 Rupees/Shr

* SAYS APPROVED QIP FLOOR PRICE OF 937.63 RUPEES PER SHARE Source text: http://bit.ly/2AJA9El Further company coverage:

BRIEF-India's Natco Pharma Sept-qtr consol profit up about 28 pct

* Sept quarter consol net profit 848 million rupees versus profit of 665 million rupees last year

BRIEF-Natco Pharma's marketing partner Mylan launches generic glatiramer acetate in U.S.

* Says marketing partner mylan launches generic glatiramer acetate in U.S. Market Source text - http://bit.ly/2xUtxo0 Further company coverage:

BRIEF-Natco Pharma gets shareholders' nod for re-appointing V.C. Nannapaneni as chairman, MD

* Gets shareholders' nod for re-appointment of V.C. Nannapaneni as chairman, MD Source text - http://bit.ly/2wuXVkS Further company coverage:

BRIEF-Natco Pharma gets shareholders' nod for reappointment of V C Nannapaneni as chairman, MD

* Gets shareholders' nod for reappointment of V C Nannapaneni as chairman, MD

BRIEF-Natco Pharma says co, Lupin get FDA nod for generic lanthanum carbonate chewable tablets‍​

* Says Natco, Lupin get FDA nod for generic lanthanum carbonate chewable tablets‍​

BRIEF-India's Natco Pharma June-qtr consol profit surges

* June quarter consol profit 940 million rupees versus profit of 477 million rupees last year

Select another date: